The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

Bibliographic Details
Main Authors: Xiaolin Zhu, Yiping Zhang, Qingyu Luo, Xiaowei Wu, Furong Huang, Tong Shu, Yong Wan, Hongyan Chen, Zhihua Liu
Format: Article
Language:English
Published: Nature Publishing Group 2021-07-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00580-w
_version_ 1830132719534735360
author Xiaolin Zhu
Yiping Zhang
Qingyu Luo
Xiaowei Wu
Furong Huang
Tong Shu
Yong Wan
Hongyan Chen
Zhihua Liu
author_facet Xiaolin Zhu
Yiping Zhang
Qingyu Luo
Xiaowei Wu
Furong Huang
Tong Shu
Yong Wan
Hongyan Chen
Zhihua Liu
author_sort Xiaolin Zhu
collection DOAJ
first_indexed 2024-12-17T06:39:26Z
format Article
id doaj.art-c530e42d15364e18a4f597940dd87a83
institution Directory Open Access Journal
issn 2059-3635
language English
last_indexed 2024-12-17T06:39:26Z
publishDate 2021-07-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj.art-c530e42d15364e18a4f597940dd87a832022-12-21T21:59:53ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352021-07-01611310.1038/s41392-021-00580-wThe deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIPXiaolin Zhu0Yiping Zhang1Qingyu Luo2Xiaowei Wu3Furong Huang4Tong Shu5Yong Wan6Hongyan Chen7Zhihua Liu8State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Gynecological Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Department of Pharmacology, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of MedicineState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Collegehttps://doi.org/10.1038/s41392-021-00580-w
spellingShingle Xiaolin Zhu
Yiping Zhang
Qingyu Luo
Xiaowei Wu
Furong Huang
Tong Shu
Yong Wan
Hongyan Chen
Zhihua Liu
The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
Signal Transduction and Targeted Therapy
title The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
title_full The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
title_fullStr The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
title_full_unstemmed The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
title_short The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
title_sort deubiquitinase usp11 promotes ovarian cancer chemoresistance by stabilizing bip
url https://doi.org/10.1038/s41392-021-00580-w
work_keys_str_mv AT xiaolinzhu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT yipingzhang thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT qingyuluo thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT xiaoweiwu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT furonghuang thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT tongshu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT yongwan thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT hongyanchen thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT zhihualiu thedeubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT xiaolinzhu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT yipingzhang deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT qingyuluo deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT xiaoweiwu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT furonghuang deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT tongshu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT yongwan deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT hongyanchen deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip
AT zhihualiu deubiquitinaseusp11promotesovariancancerchemoresistancebystabilizingbip